DexCom, Inc. (LON:0A4M)

DexCom Statistics

Total Valuation

DexCom has a market cap or net worth of GBP 19.50 billion. The enterprise value is 19.24 billion.

Market Cap	19.50B
Enterprise Value	19.24B

Important Dates

The next estimated earnings date is Thursday, October 23, 2025.

Earnings Date	Oct 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	392.16M
Shares Outstanding	n/a
Shares Change (YoY)	-2.97%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	0.31%
Owned by Institutions (%)	93.88%
Float	389.52M

Valuation Ratios

The trailing PE ratio is 46.75 and the forward PE ratio is 27.90.

PE Ratio	46.75
Forward PE	27.90
PS Ratio	6.21
PB Ratio	10.38
P/TBV Ratio	10.85
P/FCF Ratio	46.80
P/OCF Ratio	27.05
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.86, with an EV/FCF ratio of 46.18.

EV / Earnings	46.12
EV / Sales	5.99
EV / EBITDA	26.86
EV / EBIT	37.50
EV / FCF	46.18

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 1.00.

Current Ratio	1.52
Quick Ratio	1.30
Debt / Equity	1.00
Debt / EBITDA	2.69
Debt / FCF	4.52
Interest Coverage	36.17

Financial Efficiency

Return on equity (ROE) is 22.83% and return on invested capital (ROIC) is 8.44%.

Return on Equity (ROE)	22.83%
Return on Assets (ROA)	6.08%
Return on Invested Capital (ROIC)	8.44%
Return on Capital Employed (ROCE)	17.10%
Revenue Per Employee	306,259
Profits Per Employee	40,696
Employee Count	10,300
Asset Turnover	0.61
Inventory Turnover	3.05

Taxes

In the past 12 months, DexCom has paid 155.18 million in taxes.

Income Tax	155.18M
Effective Tax Rate	27.11%

Stock Price Statistics

The stock price has decreased by -5.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-5.15%
50-Day Moving Average	79.74
200-Day Moving Average	85.43
Relative Strength Index (RSI)	34.75
Average Volume (20 Days)	6,394

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.70

Income Statement

In the last 12 months, DexCom had revenue of GBP 3.14 billion and earned 417.14 million in profits. Earnings per share was 1.04.

Revenue	3.14B
Gross Profit	1.84B
Operating Income	501.59M
Pretax Income	572.31M
Net Income	417.14M
EBITDA	673.92M
EBIT	501.59M
Earnings Per Share (EPS)	1.04

Balance Sheet

The company has 2.14 billion in cash and 1.88 billion in debt, giving a net cash position of 255.47 million.

Cash & Cash Equivalents	2.14B
Total Debt	1.88B
Net Cash	255.47M
Net Cash Per Share	n/a
Equity (Book Value)	1.88B
Book Value Per Share	4.79
Working Capital	1.26B

Cash Flow

In the last 12 months, operating cash flow was 720.92 million and capital expenditures -304.30 million, giving a free cash flow of 416.63 million.

Operating Cash Flow	720.92M
Capital Expenditures	-304.30M
Free Cash Flow	416.63M
FCF Per Share	n/a

Margins

Gross margin is 58.77%, with operating and profit margins of 15.98% and 13.29%.

Gross Margin	58.77%
Operating Margin	15.98%
Pretax Margin	18.23%
Profit Margin	13.29%
EBITDA Margin	21.47%
EBIT Margin	15.98%
FCF Margin	13.27%

Dividends & Yields

DexCom does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.97%
Shareholder Yield	2.97%
Earnings Yield	2.14%
FCF Yield	2.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 13, 2022. It was a forward split with a ratio of 4.

Last Split Date	Jun 13, 2022
Split Type	Forward
Split Ratio	4

Scores

DexCom has an Altman Z-Score of 5.47 and a Piotroski F-Score of 6.

Altman Z-Score	5.47
Piotroski F-Score	6